Abstract

<p><strong>Objective: </strong>Synthesis, <em>in silico</em> absorption, distribution, metabolism, excretion, toxicity (ADMET) and <em>in vitro</em> antimicrobial screening of (<em>E</em>)-<em>N</em>-(2-(1<em>H</em>-indol-3-ylamino) vinyl)-3-(1-methyl-1<em>H</em>-indol-3-yl)-3-phenylpropanamide derivatives.<strong></strong></p><p><strong>Methods: </strong>(<em>E</em>)-<em>N</em>-(2-(1<em>H</em>-indol-3-ylamino) vinyl)-3-(1-methyl-1<em>H</em>-indol-3-yl)-3 phenylpropane-amide derivatives were synthesized by combining indole ethanolamine and substituted Meldrum’s adduct. The synthesized compounds were subjected to <em>in vitro</em> antimicrobial study by cup plate method and <em>in silico</em> ADMET properties using ACD/I-Lab 2.0.</p><p><strong>Results: </strong>The <em>in vitro </em>antimicrobial screening against precarious pathogenic microorganisms <em>viz</em>, <em>Pseudomonas aureginosa</em>, <em>Staphylococcus aureus,</em> <em>Escherichia coli, </em><em>Vibrio cholerae</em>, and the antifungal activity against <em>Candida albicans, </em><em>Aspergillus niger</em>, <em>Penicillin chrysogenum</em> and <em>Cladosporium oxysporum</em> strains. The results revealed that compounds 5b, 5c, 5d and 5e showed good antimicrobial property and obeyed the <em>in silico</em> pharmacokinetic parameters.</p><p><strong>Conclusion: </strong>The encouraging results exhibited by the compounds (<em>E</em>)-<em>N</em>-(2-(1<em>H</em>-indol-3-ylamino) vinyl)-3-(1-methyl-1<em>H</em>-indol-3-yl)-3-phenyl propanamide derivatives, 5(a-e) can be explored as possible hits in antimicrobial therapy. The molecules obey the Lipinski rule of five when tested <em>in silico </em>and can be used in understanding the quantitative structure-activity relationship (QSAR) parameters.</p>

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call